July 3, 2013 – FDA Drug Safety Communication warns of increased risk of sprue-like enteropathy with olmesartan-containing blood pressure medications.
July 3, 2013 – FDA Drug Safety Communication warns of increased risk of sprue-like enteropathy with olmesartan-containing blood pressure medications.